Search & Analyze
Popular Searches
Accretion Pharmaceuticals Ltd.
Healthcare₹170.25
CMP₹170.25
Mkt Cap₹189 Cr
P/E19.58
P/B3.46
ROE65.39%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
19.58
P/B Ratio
3.46
EV/EBITDA
13.43
Price/Sales
2.11
Dividend Yield (%)
0.00
EPS (TTM ₹)
8.70
Book Value (₹)
49.22
ROE (%)
65.39
ROCE (%)
46.33
ROA (%)
20.18
EBITDA Margin (%)
20.71
Net Profit Margin (%)
11.84
Debt/Equity
0.92
Current Ratio
1.44
Interest Coverage
7.79
Asset Turnover
1.70
Working Capital/Sales
5.56
Core EBITDA Growth (%)
357.51
P&L
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Gross Sales | 1335.25 | 5737.62 |
| Net Sales | 1335.25 | 5737.62 |
| Total Income | 1340.72 | 5747.06 |
| Total Expenditure | 1078.95 | 4549.43 |
| Operating Profit | 261.77 | 1197.63 |
| Depreciation | 22.35 | 77.45 |
| Exceptional Items | — | — |
| Profit Before Tax | 199.5 | 976.38 |
| Tax | 50.22 | 297.03 |
| Profit After Tax (PAT) | 149.28 | 679.35 |
| EPS (₹) | 1.96 | 8.48 |
| Dividend Payout % | — | — |
Balance Sheet
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Share Capital | 400 | 817 |
| Reserves | 149.29 | 711.64 |
| Shareholders Funds | 549.29 | 1528.64 |
| Total Debt | 1347.78 | 1410.35 |
| Total Liabilities | 2743.92 | 3987.44 |
| Total Assets | 2743.92 | 3987.44 |
| Book Value / Share | 13.7322 | 18.7104 |
| Assets | 2743.92 | 3987.44 |
Cash Flows
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Operating Activities | -1150.89 | 574.99 |
| Investing Activities | -547.81 | -161.08 |
| Financing Activities | 1707.86 | -418 |
| Net Cash Flow | 9.16 | -4.09 |
ACCPL
₹170.25
+0%